Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × Etoposide × Clear all

Phase

Status

Completed 15 Unknown 7 Terminated 4 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 20 Lymphoma, Large B-Cell, Diffuse 9 Lung Neoplasms 7 Burkitt Lymphoma 7 Lymphoma, Non-Hodgkin 6 Lymphoma, B-Cell 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma 5 Hodgkin Disease 5 Neoplasms, Germ Cell and Embryonal 4 Medulloblastoma 4 Leukemia, Myeloid, Acute 4 Small Cell Lung Cancer Extensive Stage 3 Neuroblastoma 3 Multiple Myeloma 3 Carcinoma, Neuroendocrine 3 Brain Neoplasms 3 Wilms Tumor 2 Urinary Bladder Neoplasms 2 Teratoma 2 Seminoma 2 SCLC,Extensive Stage 2 Retinoblastoma 2 Recurrence 2 Plasmablastic Lymphoma 2 Hematologic Neoplasms 2 Glioma 2 Glioblastoma 2 Extensive Stage Small Cell Lung Cancer 2 Ependymoma 2

Interventions

Bevacizumab 36 Paclitaxel 27 Carboplatin 23 pembrolizumab 21 Specimen Handling 15 olaparib 13 Cisplatin 11 niraparib 10 Magnetic Resonance Spectroscopy 10 Cyclophosphamide 10 Blood Specimen Collection 10 fludarabine 8 Fulvestrant 8 Drug Therapy 8 Biopsy 8 Taxes 6 liposomal doxorubicin 5 Topotecan 5 Gemcitabine 5 Fluorouracil 5 Doxorubicin 5 mirvetuximab soravtansine 4 cemiplimab 4 aldesleukin 4 abemaciclib 4 Surveys and Questionnaires 4 Oxaliplatin 4 Interleukin-2 4 Immunoglobulin G 4 Hyperthermic Intraperitoneal Chemotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡